Audrey Vinchent

<scp>MET</scp> exon 14 skipping mutation is a hepatocyte growth factor (<scp>HGF</scp>)‐dependent oncogenic driver <i>in vitro</i> and in humanised <i>HGF</i> knock‐in mice

Marie Fernandes, Brynna Hoggard, Philippe Jamme et al. · Molecular Oncology · 2023 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17

Control of cell death/survival balance by the MET dependence receptor

Leslie Duplaquet, Catherine Leroy, Audrey Vinchent et al. · eLife · 2020 · 20 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Transforming properties of <scp>MET</scp> receptor exon 14 skipping can be recapitulated by loss of the <scp>CBL</scp> ubiquitin ligase binding site

Marie Fernandes, Sonia Paget, Zoulika Kherrouche et al. · FEBS Letters · 2023 · 19 citations · Full text

Medicine, Molecular Biology, Oncology +13

Hypoxia leads to decreased autophosphorylation of the MET receptor but promotes its resistance to tyrosine kinase inhibitors

Meriem Sarah Mekki, Alexandra Mougel, Audrey Vinchent et al. · Oncotarget · 2018 · 12 citations · Full text

Medicine, Cancer Biology, Oncology +17

MET receptor variant R970C favors calpain-dependent generation of a fragment promoting epithelial cell scattering

Rémi Montagne, A. Baranzelli, Ghaffar Muharram et al. · Oncotarget · 2017 · 10 citations · Full text

Medicine, Cancer Biology, Oncology +13